Parkwood LLC’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,390
| Closed | -$477K | – | 104 |
|
|
2024
Q2 | $477K | Buy |
+11,390
| New | +$477K | 0.06% | 111 |
|
|
2023
Q1 | – | Sell |
-21,469
| Closed | -$283K | – | 165 |
|
|
2022
Q4 | $283K | Sell |
21,469
-11,883
| -36% | -$157K | 0.04% | 128 |
|
|
2022
Q3 | $452K | Sell |
33,352
-398
| -1% | -$5.39K | 0.07% | 113 |
|
|
2022
Q2 | $412K | Buy |
33,750
+5,492
| +19% | +$67K | 0.07% | 115 |
|
|
2022
Q1 | $405K | Sell |
28,258
-3,870
| -12% | -$55.5K | 0.07% | 103 |
|
|
2021
Q4 | $634K | Buy |
32,128
+11,351
| +55% | +$224K | 0.11% | 84 |
|
|
2021
Q3 | $449K | Buy |
+20,777
| New | +$449K | 0.05% | 102 |
|